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ABSTRACT 
Aim: Differences in early graft function between kidney transplant recipients previously 
managed with either haemodialysis (HD) or peritoneal dialysis are well described. However, 
only two single-centre studies have compared graft and patient outcomes between extended 
hour and conventional HD patients, with conflicting results. 
Methods: This study compared the outcomes of all extended hour (≥24 hours/week) and 
conventional HD patients transplanted in Australia and New Zealand between 2000 and 
2014. The primary outcome was delayed graft function (DGF), defined in an ordinal manner 
as either a spontaneous fall in serum creatinine of less than 10% within 24 hours, or the need 
for dialysis within 72 hours following transplantation. Secondary outcomes included the 
requirement for dialysis within 72 hours post-transplant, acute rejection, estimated 
glomerular filtration rate at 12 months, death-censored graft failure, all-cause and 
cardiovascular mortality, and a composite of graft failure and mortality. 
Results: A total of 4,935 HD patients (378 extended hour HD, 4,557 conventional HD) 
received a kidney transplant during the study period. Extended hour HD was associated with 
an increased likelihood of DGF compared with conventional HD (adjusted proportional odds 
ratio 1.33; 95% confidence interval 1.06–1.67). There was no significant difference between 
extended hour and conventional HD in terms of any of the secondary outcomes. 
Conclusion: Compared to conventional HD, extended hour HD was associated with DGF, 
although long-term graft and patient outcomes were not different. 
 
Keywords: Delayed graft function, extended hour haemodialysis, graft function, graft 
survival, renal replacement therapy, renal transplantation. 
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INTRODUCTION 
Delayed graft function (DGF) continues to pose a significant challenge to the practice of 
kidney transplantation and has important implications for graft and patient outcomes. Despite 
advances in transplantation practice, the incidence of DGF has increased from 14.7% in 
19921 to 27.0% in 20122, which corresponds to the increasing utilisation of higher risk 
kidneys from expanded criteria donors (ECD)3 and donation after circulatory death (DCD)4. 
The pathophysiological mechanisms underlying the development of DGF are not entirely 
understood, but it is thought to relate to a combination of ischaemic, inflammatory, 
microcirculatory and immunological insults which culminate in tissue injury and impaired 
early function5. Although the definition of DGF varies widely6, from failure of creatinine to 
fall within a defined period to requirement for post-transplant dialysis, the clinical impact of 
DGF on graft outcomes has been clearly established1,7–9. Epidemiological studies have 
indicated that DGF is associated with a 41% increased risk of graft loss, as well as a 38% 
increase in the risk of acute rejection, highlighting that interventions aimed at reducing the 
incidence of DGF may potentially lead to improved graft outcomes8,9. 
 
Several donor, graft and recipient characteristics are associated with a higher incidence of 
DGF, including greater donor age or terminal creatinine, longer duration of cold or warm 
ischaemia, higher immunological risk, and recipient male sex, indigenous race, higher body 
mass index [BMI], diabetic status and longer waiting time6,10,11. A number of large 
observational studies have examined the interaction between pre-transplant dialysis modality 
and post-transplant graft and patient outcomes12–22. Although a clear association has not been 
established, several studies have shown that recipients maintained on peritoneal dialysis prior 
to transplant were less likely to experience DGF compared to those maintained on 
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haemodialysis (HD), possibly due to differences in residual renal function, extracellular fluid 
volume, peripheral vascular resistance and complement and leukocyte activation19,23–25. 
 
It remains uncertain whether a similar disparity in early graft function exists between patients 
treated with extended hour and conventional HD. In observational studies, extended hour HD 
has been associated with improvements in survival26, blood pressure control27, biochemical 
profile28–30, and cardiac structure and function31. It is plausible that differences in 
extravascular fluid volume and haemodynamic parameters between extended hour and 
conventional HD patients could affect allograft function in the early post-transplant period. 
Two single-centre observational studies have examined this effect, by comparing nocturnal 
and conventional HD patients32,33. Both studies were limited by small patient numbers, short 
follow-up duration, and lack of multivariable adjustment for differences in characteristics 
between the groups. With increasing interest in the use of extended hour HD in suitable 
patients, it is important to explore the potential implications of this therapy in patients who 
are transplant candidates, especially if early graft function may differ. Therefore, this study 
was conducted to examine the effect of pre-transplant HD modality on graft and patient 
outcomes using data from the Australia and New Zealand Dialysis and Transplant 
(ANZDATA) Registry. 
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METHODS 
STUDY DESIGN 
This was a retrospective multi-centre study using patient records from the ANZDATA 
Registry between 1 January 2000 and 31 December 2014. The ANZDATA Registry collects 
information annually from all units throughout Australia and New Zealand, concerning all 
patients receiving chronic renal replacement therapy34. All recipients of living or deceased 
donor kidney transplants who received HD for at least 3 months prior to transplantation were 
included in this study. Patients aged less than 18 years at commencement of HD and multi-
organ transplant recipients were excluded. 
 
DATA COLLECTION 
Data on recipient demographics (age, sex, race), recipient comorbidities (cause of end stage 
kidney disease [ESKD], waiting time, BMI, diabetes, smoking, ischaemic heart disease 
[IHD], peripheral vascular disease [PVD], cerebrovascular disease [CVD], prior graft), donor 
characteristics (age, sex, source [live donation, donation after brain death, donation after 
circulatory death], donor terminal creatinine [for deceased donors]), transplant factors 
(transplant centre state of Australia or New Zealand, total ischaemia time, human leukocyte 
antigen [HLA] mismatches, transplant era), and pre-transplant HD modality (extended hour 
or conventional) were recorded. Extended hour HD was defined as a weekly treatment time 
greater than or equal to 24 hours. This definition maintains adequate separation in weekly 
treatment time between conventional and extended hour HD patients and is consistent with 
that used in randomised controlled trials in this area35. Weekly treatment time was derived 
from the most recent ANZDATA record prior to transplantation. 
 
CLINICAL OUTCOMES 
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The primary outcome measure was DGF, which was examined as an ordinal outcome. The 
reference group was immediate graft function, defined as a spontaneous fall in serum 
creatinine concentration by 10% or more within 24 hours. The definition of DGF included 
slow graft function (a spontaneous fall in serum creatinine concentration of less than 10% 
within 24 hours) and delayed graft function requiring dialysis (the need for dialysis within 72 
hours following transplantation). Secondary outcomes included: post-transplant dialysis 
within 72 hours (examined as a binary outcome); acute rejection; estimated glomerular 
filtration rate (eGFR) at 12 months; death-censored graft failure; all-cause and cardiovascular 
mortality; and a composite of graft failure and mortality. eGFR was calculated using the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation36. Graft failure 
was defined as transfer to dialysis or re-transplantation. Cardiovascular mortality included 
deaths due to myocardial ischaemia, cardiac failure, cardiac arrest, pulmonary oedema, and 
hyperkalaemia. 
 
STATISTICAL ANALYSES 
Baseline characteristics were expressed as numbers and percentages, means (± standard 
deviation [SD]), or medians (interquartile range [IQR]), as appropriate. Group comparisons 
were performed using the chi-squared test, unpaired t-test, or Wilcoxon rank sum test, as 
dictated by data characteristics. Univariable and multivariable ordinal (proportional odds) 
logistic regression models were used to examine the primary outcome. These models estimate 
a common odds ratio across each cutoff of the ordered outcome. The Brant Test was used to 
check the proportional odds assumption. Binary logistic regression was used to examine the 
impact of dialysis modality on dialysis requirement within the first 72 hours. Negative 
binomial regression was used to compare acute rejection rates. Graft function (eGFR) at 12 
months was compared using a multivariable linear regression model. Graft and patient 
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survival were evaluated by Kaplan-Meier methods and univariable and multivariable-
adjusted Cox regression models. Regression model diagnostics performed to evaluate 
appropriateness of the models used graphical techniques and formal model fitting tests. A 
variance inflation factor was calculated to assess multicollinearity. All multivariable models 
were adjusted for covariates that differed at baseline or were known to be associated with the 
outcomes of interest. These included recipient characteristics (age, sex, race, BMI, cause of 
ESKD, waiting time, diabetes, smoking status, IHD, PVD, CVD, prior graft), donor 
characteristics (age, sex, source) and transplantation factors (transplant centre state, total 
ischaemia time, HLA mismatches, transplant era). Transplant centre state was examined as a 
fixed effect variable in the primary analysis, but also as a random effect variable in sensitivity 
analyses for each outcome of interest. 
 
Due to baseline differences between the groups, two different matching techniques were 
applied and are presented as sensitivity analyses: coarsened exact matching (CEM) and 
propensity score matching (PSM). CEM involves the temporary coarsening of data followed 
by exact matching, with analyses run on uncoarsened data37,38. It has many advantages in this 
setting, including a reduced sensitivity to measurement error, control over the degree of 
imbalance between groups, and the ability to alter balance on covariates independently. In 
both CEM and PSM models, patients were matched on demographic and clinical 
characteristics that differed between extended hour and conventional HD patients. These 
included recipient age, sex, diabetic status, waiting time, donor age, donor source and total 
ischaemia time. An additional sensitivity analysis including donor terminal creatinine in the 
multivariable models was performed for recipients of deceased donor kidneys. The 
multivariable models included all other covariates that were different at baseline, as well as 
those associated with the outcome of interest in univariable analyses (S1-S5 Tables). Data 
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were analysed using the software package Stata/SE version 14.0 (StataCorp College Station, 
TX). Two-sided P values <0.05 were considered statistically significant. 
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RESULTS 
STUDY POPULATION 
Between 1 January 2000 and 31 December 2014, 5,098 HD patients underwent renal 
transplantation in Australia and New Zealand (Figure 1). Of these, 4,935 (97%) patients had 
complete records detailing HD treatment time and DGF status and were included in the 
analysis. There were 378 (8%) extended hour and 4,557 (92%) conventional HD patients. 
The median duration of follow up was 4.6 years (IQR 2.2 – 6.8) for extended hour HD and 
5.1 years (IQR 2.4 – 8.4) for conventional HD patients. Baseline characteristics of the study 
population are displayed in Table 1. Compared to conventional HD, patients who received 
extended hour HD were more likely to be male, obese, and to have had a longer waiting time. 
They were less likely to be Aboriginal or Torres Strait Islander, to have diabetic nephropathy 
and to have received a kidney transplant in the earliest transplant era. 
 
DELAYED GRAFT FUNCTION 
Pre-transplant HD modality was associated with a disparity in the rate of DGF, categorised as 
slow graft function (SGF) or delayed graft function requiring dialysis (DGF-D) (Figure 2, 
Tables 2-3). A total of 1,979 patients developed DGF (191 extended hour HD, 1,788 
conventional HD). Extended hour HD was associated with a higher likelihood of DGF in 
univariable (proportional odds ratio [OR] 1.47; 95% confidence interval [CI] 1.21 – 1.79, P 
<0.001) and multivariable adjusted models (adjusted proportional OR 1.33; 95% CI 1.06 – 
1.67, P = 0.01). 
 
POST-TRANSPLANT DIALYSIS 
Overall, 1,249 patients received dialysis after transplant (114 extended hour HD, 1,135 
conventional HD) (Table 2). Examined as a binary outcome, post-transplant dialysis was 
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required more frequently in extended hour HD patients in the univariable analysis (OR 1.30; 
95% CI 1.03 – 1.64, P = 0.02) (Figure 2, Table 3), but not following multivariable adjustment 
(adjusted OR 1.23; 95% CI 0.94 – 1.61, P = 0.12). 
 
ACUTE REJECTION 
During the study period, 1,373 patients had at least one episode of acute rejection (103 
extended hour HD, 1,270 conventional HD). There was no difference in the number of 
episodes or rate of acute rejection between extended hour and conventional HD patients 
(adjusted incident rate ratio 0.95, 95% CI 0.77 – 1.17, P = 0.61) (Tables 2-3). 
 
GRAFT FUNCTION 
Mean eGFR at 12 months was not significantly different between transplant recipients who 
were maintained on extended hour or conventional HD prior to transplantation (52.3±18.9 vs 
54.1±18.9 ml/min/1.73m2, P = 0.10) (Figure 3). The unadjusted and adjusted beta 
coefficients comparing extended hour and conventional HD patients were -1.77 (95% CI -
3.89 – 0.35, P = 0.10) and -1.40 (95% CI -3.32 – 0.53, P = 0.16), respectively. 
 
GRAFT FAILURE 
A total of 618 patients developed graft failure (36 extended hour HD, 582 conventional HD). 
The two groups did not differ significantly with respect to the cause of graft failure (Table 4). 
Time to death-censored graft failure was comparable between extended hour and 
conventional HD patients in unadjusted (hazard ratio [HR] 0.88; 95% CI 0.63 – 1.23, P = 
0.45) and multivariable adjusted models (adjusted HR 0.89; 95% CI 0.63 – 1.26, P = 0.51) 
(Figure 4, Figure 5(a)). 
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ALL-CAUSE MORTALITY 
There were 652 deaths during the study period (23 extended hour HD, 629 conventional HD) 
(Table 2). There was no significant difference in cause of death between the two groups 
(Table 4). In unadjusted models, time to all-cause mortality was significantly longer in 
patients treated with extended hour HD compared to those treated with conventional HD (HR 
0.55, 95% CI 0.36 – 0.83, P = 0.004) (Table 3, Figure 4, Figure 5 (b)). However, this 
difference was no longer statistically significant following multivariable adjustment (adjusted 
HR 0.82, 95% CI 0.53 – 1.25, P = 0.35). 
 
CARDIOVASCULAR MORTALITY 
Cardiovascular death accounted for 178 deaths in the study (8 extended hour HD, 170 
conventional HD) (Table 2). Time to cardiovascular mortality did not differ between the two 
groups in unadjusted (HR 0.71, 95% CI 0.35 – 1.44, P = 0.34) or multivariable models 
(adjusted HR 1.15, 95% CI 0.56 – 2.40, P = 0.70) (Table 3, Figure 4, Figure 5(c)). 
 
COMPOSITE OF DEATH OR GRAFT FAILURE 
Graft failure or death occurred in 1,099 patients (52 extended hour HD, 1,047 conventional 
HD). Extended hour HD was associated with a favourable time to the composite outcome in 
the unadjusted analysis (HR 0.71, 95% CI 0.54 – 0.94, P = 0.02) (Table 2, Figure 4, Figure 
5(d)). However, following multivariable adjustment, there was no statistically significant 
difference between extended hour and conventional HD patients (adjusted HR 0.83, 95% CI 
0.63 – 1.11, P = 0.22). 
 
SENSITIVITY ANALYSES 
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The coarsened exact matched analysis included 2,357 patients (352 extended hour HD, 2,005 
conventional HD). In the extended hour HD cohort, patients were more likely to be obese, to 
smoke and to have received a prior kidney transplant. Other baseline characteristics were 
similar (S6 Table). Extended hour HD was associated with an increased risk of DGF 
compared to conventional HD (adjusted proportional OR 1.28, 95% CI 1.02 – 1.61, P = 
0.03). There was no difference in any of the secondary outcomes between the two groups (S7 
Table). 
 
In the propensity score matched analysis of 1,491 patients, there were 378 extended hour HD 
patients and 1,113 conventional HD patients. Extended hour HD patients were more likely to 
be obese, Caucasian, have a longer waiting time, and to have received a prior kidney 
transplant (S8 Table). Compared to conventional HD, there was an increased likelihood of 
DGF in extended hour HD patients (adjusted proportional OR 1.35, 95% CI 1.06 – 1.71, P = 
0.02). There was also a trend towards a lower eGFR at 12 months in patients previously 
managed with extended hour HD (adjusted coefficient -2.48, 95% CI -4.96 – 0.01, P = 0.05). 
Otherwise, secondary outcomes did not differ (S9 Table). 
 
The primary analysis was repeated including state of transplantation as a random effect and 
results were comparable (S10 Table). There were no differences in findings when donor 
terminal creatinine was included in the multivariable models for recipients of deceased donor 
kidneys.
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DISCUSSION 
In this large cohort of HD patients from Australia and New Zealand, compared with 
conventional HD, extended hour HD was associated with an increased risk of DGF post-
kidney transplant, defined categorically as either a spontaneous fall in serum creatinine 
concentration of less than 10% within 24 hours, or the need for dialysis within the first 72 
hours following transplantation. However, acute rejection, renal function (eGFR) at 12 
months, death-censored graft failure, all-cause and cardiovascular mortality, and a composite 
of graft failure and mortality were comparable. 
 
These findings contrast with those of two previous small, short-duration, single-centre 
observational studies which examined DGF, defined as post-transplant dialysis requirement, 
in nocturnal HD patients32,33. McCormick et al32 reported no significant differences in DGF 
(64% vs 41%, P = 0.15), 1-year graft function (eGFR 53±6 vs. 59±5ml/min, P = 0.43) or 
graft survival (92% vs 95%, P = 0.75) between 15 nocturnal HD and 29 conventional HD 
patients between 1994 and 2002. Similarly, Pauly et al33 observed similar rates of post-
transplant dialysis requirement (42.9% vs. 36.8%, P = 0.43), graft survival and patient 
survival between 36 nocturnal HD and 68 conventional HD patients between 1994 and 2006. 
The sample sizes and follow-up durations of these studies were considerably smaller than 
those of the present investigation, which reduced their power to detect a difference in 
outcomes between the groups. Minimal information on patient characteristics was provided 
and neither study examined outcomes in multivariable analyses. Their single-centre design 
and examination of cohorts from an earlier transplant era also limited the generalisability of 
their results. 
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Since dialysis is performed until the time of kidney transplant, there are a number of 
biologically plausible hypotheses that could explain the observed differences in the rates of 
DGF between extended hour and conventional HD patients. Extended hour HD is associated 
with improved blood pressure control39, reduced peripheral vascular resistance40, reduced 
extravascular volume and increased weekly sodium removal41. Compounded by the 
peripheral vasodilatation induced by general anaesthesia, these factors may increase the risk 
of intraoperative hypotension and allograft hypoperfusion. Although the present study does 
not include data on these events, this hypothesis is supported by an observational study, in 
which extended hour HD patients were at greater risk of intraoperative hypotension32. The 
effect of intraoperative hypotension on allograft perfusion may be further amplified by other 
perioperative vascular changes, including pathologic vasoconstriction within the allograft in 
response to ischaemic injury, dysregulation of intraglomerular pressure at a microcirculatory 
level, and calcineurin inhibitor-induced afferent and efferent arteriolar vasoconstriction42,43. 
The vascular effects of calcineurin inhibition may be further worsened by states of salt 
depletion, which are more likely to be seen in extended hour HD patients44,45. It is also 
plausible that due to a lower pre-operative serum creatinine, extended hour HD patients may 
have been at greater risk of graft function misclassification, since the definition relies on a 
spontaneous fall in serum creatinine. 
 
These findings have important clinical implications because hypovolemia and intraoperative 
hypotension are preventable and modifiable. Consideration should be given to ensuring 
adequate intravascular volume pre-operatively and intraoperatively, especially in patients 
having undertaken extended hour HD. Ultrafiltration should be avoided prior to surgery25. 
Intraoperative hypotension should be managed promptly with fluid and vasopressor support 
to maintain graft perfusion. 
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The strengths of this study lie in its large size and extended duration of follow up. It included 
all HD patients who received a kidney transplant in Australia and New Zealand between 
2000 and 2014, making the study population representative of a broad range of patient 
demographics and comorbidities. Limitations of this study include the absence of available 
data on additional factors that could have affected the risk of DGF, including recipient fluid 
status at the time of transplantation, blood pressure and use of antihypertensive medications, 
immunologic variables other than HLA matching, and induction immunosuppression 
regimen. Additionally, detailed information regarding the timing of the most recent dialysis 
prior to transplantation, the indication for and number of dialysis sessions required post-
transplant, and the duration of DGF was also unavailable. Next, the ANZDATA registry 
collects data on early graft function in a format that differs from some definitions of DGF. 
Firstly, the data are recorded categorically (immediate, slow and delayed graft function). 
Secondly, the requirement for post-transplant dialysis is examined within the first 72 hours 
rather than within the first 7 days. However, the examination of DGF as an ordinal outcome 
has several advantages compared to a binary definition of dialysis requirement post-
transplant. First, it captures patients with poor graft function who do not receive dialysis; 
second, it avoids misclassification due to dialysis for reasons other than poor graft function; 
and third, it minimises centre effect with respect to dialysis practice2. To facilitate direct 
comparison of outcomes from this study to the existing published literature, requirement for 
post-transplant dialysis was also examined as a secondary outcome. Nonetheless, conclusions 
from the current study can only be limited to associations, and causal relationships could not 
be inferred in the setting of an observational study design. Indication bias with residual 
confounding could not be excluded. Submission of patient data to ANZDATA is voluntary 
and there is no routine audit of data; therefore, there is a risk of coding or reporting bias. 
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In conclusion, this study demonstrated an association between extended hour HD and an 
increased risk of DGF compared with conventional HD, although long-term graft and patient 
outcomes did not differ. It is plausible that this association arises due to differences in 
intravascular volume, haemodynamic parameters, and microcirculatory abnormalities in the 
early post-transplant period. Further studies are required to address this question and explore 
possible mechanisms. The physiological benefits of extended hour HD are well described; 
however, this study suggests that when patients receiving extended hour HD undergo renal 
transplantation consideration should be given to the potentially increased risk of DGF. 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
ACKNOWLEDGEMENTS 
The authors would like to acknowledge the substantial contributions of the Australian and 
New Zealand nephrology community who provided information to, and maintained, the 
ANZDATA Registry database. The ANZDATA Registry is funded by the Australian Organ 
and Tissue Donation and Transplantation Authority, the New Zealand Ministry of Health, 
and Kidney Health Australia. The interpretation and reporting of these data are the 
responsibility of the authors and should not be seen as official policy of ANZDATA. 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
REFERENCES 
1.  Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk 
factors and implications for renal allograft survival. Transplantation. 1997;63:968–74.  
2.  Orandi BJ, James NT, Hall EC, et al. Center-level variation in the development of 
delayed graft function after deceased donor kidney transplantation. Transplantation. 
2015;99:997–1002.  
3.  Collins MG, Chang SH, Russ GR, McDonald SP. Outcomes of transplantation using 
kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 
2005. Transplantation. 2009;87:1201–9.  
4.  Summers DM, Johnson RJ, Allen J, et al. Analysis of factors that affect outcome after 
transplantation of kidneys donated after cardiac death in the UK: A cohort study. 
Lancet. 2010;376:1303–11.  
5.  Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am 
J Transplant. 2011;11:2279–96.  
6.  Yarlagadda SG, Coca SG, Garg AX, et al. Marked variation in the definition and 
diagnosis of delayed graft function: A systematic review. Nephrol Dial Transplant. 
2008;23:2995–3003.  
7.  Feldman HI, Gayner R, Berlin JA, et al. Delayed function reduces renal allograft 
survival independent of acute rejection. Nephrol Dial Transplant. 1996;11:1306–13.  
8.  Yarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between 
delayed graft function and allograft and patient survival: a systematic review and 
meta-analysis. Nephrol Dial Transplant. 2009;24:1039–47.  
9.  Butala NM, Reese PP, Doshi MD, Parikh CR. Is delayed graft function causally 
associated with long-term outcomes after kidney transplantation? Instrumental variable 
analysis. Transplantation. 2013;95:1008–14.  
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
10.  Meurisse M, Albert A, Defraigne J, Bonnet P, Honore P. Multiple risk factor analysis 
of non-immunological delayed graft function after kidney transplantation. Clin 
Transplant. 1988;2:312–8.  
11.  Irish WD, Ilsley JN, Schnitzler M a, Feng S, Brennan DC. A risk prediction model for 
delayed graft function in the current era of deceased donor renal transplantation. Am J 
Transplant. 2010;10:2279–86.  
12.  Cacciarelli T, Sumrani NB, DiBenedetto A, Hong JH, Sommer BG. The influence of 
mode of dialysis pretransplantation onlong-term renal allograft outcome. Ren Fail. 
1993;15:545–50.  
13.  Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation: The 
impact of dialysis pre-transplant. Kidney Int. 1998;53:767–72.  
14.  Van Biesen W, Vanholder R, Van Loo A, Van Der Vennet M, Lameire N. Peritoneal 
dialysis favorably influences early graft function after renal transplantation compared 
to hemodialysis. Transplantation. 2000;69:508–14.  
15.  Joseph JT, Jindal RM. Influence of dialysis on post-transplant events. Clin Transpl. 
2002;16:18–23.  
16.  Perez Fontan MP, Rodriguez-Carmona A, Garcia Falcon T, et al. Renal transplantation 
in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 1996;16:48–51.  
17.  Sezer S, Karakan S, Özdemir Acar FN, Haberal M. Dialysis as a bridge therapy to 
renal transplantation: comparison of graft outcomes according to mode of dialysis 
treatment. Transplant Proc. 2011;43:485–7.  
18.  Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant 
outcomes in peritoneal and hemodialysis patients. Kidney Int. 2002;62:1423–30.  
19.  Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, Baird BC, Cheung AK. The role 
of pretransplantation renal replacement therapy modality in kidney allograft and 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
recipient survival. Am J Kidney Dis. 2005;46:537–49.  
20.  Vanholder R, Heering P, Van Loo A, et al. Reduced incidence of acute renal graft 
failure in patients treated with peritoneal dialysis compared with hemodialysis. Am J 
Kidney Dis. 1999;33:934–40.  
21.  Dipalma T, Fernández-Ruiz M, Praga M, et al. Pre-transplant dialysis modality does 
not influence short- or long-term outcome in kidney transplant recipients: analysis of 
paired kidneys from the same deceased donor. Clin Transplant. 2016;30:1097–107.  
22.  Van Biesen W, Veys N, Vanholder R, Lameire N. The impact of the pre-transplant 
renal replacement modality on outcome after cadaveric kidney transplantation: The 
Ghent experience. Contrib Nephrol. 2006;150:254–8.  
23.  Bleyer AJ, Burkart JM, Russell GB, Adams PL. Dialysis modality and delayed graft 
function after cadaveric renal transplantation. J Am Soc Nephrol. 1999;10:154–9.  
24.  Weinstein T, Fishman P, Djaldetti M, Levi J. Cytokine production by mononuclear 
cells from patients with chronic renal failure. Isr J Med Sci. 1993;29:183–6.  
25.  Van Loo A, Vanholder R, Bernaert P, et al. Pretransplantation Hemodialysis Renal 
Graft Function Strategy Influences Early Renal Graft Function. J Am Soc Nephrol. 
1998;9:473–81.  
26.  Innes A, Charra B, Burden RP, Morgan AG, Laurent G. The effect of long, slow 
haemodialysis on patient survival. Nephrol Dial Transplant. 1999;14:919–22.  
27.  Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. 
Nephrol Dial Transpl. 1999;14:2835–40.  
28.  Rocco M V, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home 
hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 
2011;80:1080–91.  
29.  Tang HL, Wong JHS, Poon CKY, et al. One year experience of nocturnal home 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
haemodialysis with an alternate night schedule in Hong Kong. Nephrology. 
2011;16:57–62.  
30.  Li JW, Wong JHS, Chak WL, Chau KF. Effect of incident nocturnal home 
hemodialysis versus incident continuous ambulatory peritoneal dialysis on 
employment rate, clinical, and laboratory outcomes: A 1-year retrospective 
observation study. Hemodial Int. 2017;in press.  
31.  Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left 
ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 
2002;61:2235–9.  
32.  McCormick BB, Pierratos A, Fenton S, et al. Review of clinical outcomes in nocturnal 
haemodialysis patients after renal transplantation. Nephrol Dial Transpl. 2004;19:714–
9.  
33.  Pauly RP, Asad RA, Hanley JA, et al. Long-term clinical outcomes of nocturnal 
hemodialysis patients compared with conventional hemodialysis patients post-renal 
transplantation. Clin Transplant. 2009;23:47–55.  
34.  Mcdonald SP. Australia and New Zealand Dialysis and Transplant Registry. Kidney 
Int Suppl. 2015;5:39–44.  
35.  Jardine MJ, Zuo L, Gray NA, et al. Design and participant baseline characteristics of 
“A Clinical Trial of IntensiVE Dialysis”: The ACTIVE Dialysis Study. Nephrology. 
2015;20:257–65.  
36.  Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular 
filtration rate. Ann Intern Med. 2009;150:604–12.  
37.  Blackwell M, Iacus S, King G, Porro G. CEM: Coarsened exact matching in Stata. 
Stata J. 2009;9:524–46.  
38.  Stuart EA. Matching methods for causal inference: A review and a look forward. Stat 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Sci. 2010;25:1–21.  
39.  Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood 
pressure management in patients undergoing quotidian hemodialysis. Am J Kidney 
Dis. 2003;42:13–7.  
40.  Chan CT, Harvey PJ, Picton P, et al. Short-term blood pressure, noradrenergic, and 
vascular effects of nocturnal home hemodialysis. Hypertension. 2003;42:925–31.  
41.  Chazot C, Jean G. Control of extracellular volume. Semin Dial. 2014;27:335–9.  
42.  Conger JD, Robinette JB, Hammond WS. Differences in vascular reactivity in models 
of ischemic acute renal failure. Kidney Int. 1991;39:1087–97.  
43.  Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-
induced vasoconstriction in isolated rat renal arterioles. J Clin Invest. 1993;91:2144–9.  
44.  Naesens M, Kuypers DRJ, Sarwal M. In-Depth Review Calcineurin Inhibitor 
Nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481–508.  
45.  Chaumont M, Racapé J, Broeders N, et al. Delayed Graft Function in Kidney 
Transplants: Time Evolution, Role of Acute Rejection, Risk Factors, and Impact on 
Patient and Graft Outcome. J Transplant. 2015;2015:1–9.  
  
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
SUPPORTING INFORMATION LEGENDS 
S1 Table. Ordinal logistic regression analysis of the association between delayed graft 
function and recipient, donor, and transplant characteristics in 4,935 extended hour and 
conventional haemodialysis patients. 
S2 Table. Binary logistic regression analysis of the association between post-transplant 
dialysis requirement and recipient, donor, and transplant characteristics in 4,935 extended 
hour and conventional haemodialysis patients. 
S3 Table. Negative binomial regression analysis of the association between acute rejection 
and recipient, donor, and transplant characteristics in 4,935 extended hour and conventional 
haemodialysis patients. 
S4 Table. Linear regression analysis of the association between estimated glomerular 
filtration rate at 12 months and recipient, donor, and transplant characteristics in 4,935 
extended hour and conventional haemodialysis patients. 
S5 Table. Log rank analysis of the association between survival outcomes and recipient, 
donor, and transplant characteristics in 4,935 extended hour and conventional haemodialysis 
patients. 
S6 Table. Baseline characteristics of a coarsened exact matched cohort of kidney transplant 
recipients previously managed with extended hour (n = 352) or conventional (n = 2,005) 
haemodialysis. 
S7 Table. Regression analyses of post-kidney transplant outcomes in a coarsened exact 
matched cohort of 352 extended hour haemodialysis (HD) patients compared with 2,005 
conventional HD patients. 
S8 Table. Baseline characteristics of a propensity score matched cohort of kidney transplant 
recipients previously managed with extended hour (n = 378) or conventional (n = 1,113) 
haemodialysis. 
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S9 Table. Regression analyses of post-kidney transplant outcomes in a propensity score 
matched cohort of 378 extended hour haemodialysis (HD) patients compared with 1,113 
conventional HD patients. 
S10 Table. Regression analyses of post-kidney transplant outcomes in 378 extended hour 
haemodialysis (HD) patients compared with 4,557 conventional HD patients including 
transplant state as a random effect. 
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FIGURE LEGENDS 
Figure 1. Study flow diagram. 
Figure 2. Odds of delayed graft function (DGF) and dialysis requirement (examined as a 
binary outcome) following kidney transplantation in 378 extended hour haemodialysis (HD) 
patients compared with 4,557 conventional HD patients. 
Figure 3. Estimated glomerular filtration rate (eGFR) at 12 months in 378 extended hour 
haemodialysis (HD) patients compared with 4,557 conventional HD patients. 
Figure 4. Unadjusted and adjusted Cox proportional hazards analyses for death-censored 
graft failure, all-cause death, cardiovascular death, and a composite of death or graft failure in 
378 extended hour haemodialysis (HD) patients compared with 4,557 conventional HD 
patients. 
Figure 5. Kaplan-Meier analysis of (a) graft survival, (b) patient survival, (c) cardiovascular 
survival and (d) composite of patient and graft survival in 378 extended hour haemodialysis 
(HD) patients compared with 4,557 conventional HD patients.
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Table 1. Baseline characteristics of kidney transplant recipients previously managed 
with extended hour (n = 378) or conventional (n = 4557) haemodialysis. 
 All  
(n = 4935) 
Extended hour 
HD (n = 378) 
Conventional HD 
(n = 4557) 
Standardised 
mean difference 
P value 
 
Male 3257 (66.0%) 282 (74.6%) 2975 (65.3%) 0.16 <0.001 
Age (years) 49.5 ± 12.9 47.9 ± 11.9 49.6 ± 12.9 0.14 0.01 
BMI (kg/m2) 
   <18.5 
   18.5-<25 
   25-30 
   >30 
 
139 (2.9%) 
1757 (36.3%) 
1756 (36.3%) 
1183 (24.5%) 
 
5 (1.3%) 
118 (31.7%) 
130 (35.0%) 
119 (32.0%) 
 
134 (3.0%) 
1639 (36.7%) 
1626 (36.4%) 
1064 (23.8%) 
 
0.09 
0.09 
0.03 
0.15 
<0.001 
 
 
 
 
Racial origin 
   Caucasian 
   ATSI 
   MPI 
   Asian 
   Other 
 
3889 (78.8%) 
214 (4.3%) 
278 (5.6%) 
248 (5.0%) 
306 (6.2%) 
 
317 (83.9%) 
2 (0.5%) 
22 (5.8%) 
20 (5.3%) 
17 (4.5%) 
 
3572 (78.4%) 
212 (4.7%) 
256 (5.6%) 
228 (5.0%) 
289 (6.3%) 
 
0.11 
0.19 
0.01 
0.01 
0.06 
<0.001 
 
 
 
 
 
Cause of ESKD 
   GN 
   Diabetes 
   Renovascular 
   Cystic 
   Reflux 
   Other 
 
2218 (45.0%) 
518 (12.5%) 
301 (6.1%) 
788 (16.0%) 
376 (7.6%) 
633 (12.8%) 
 
188 (49.7%) 
26 (6.9%) 
18 (4.8%) 
73 (19.3%) 
28 (7.4%) 
45 (11.9%) 
 
2030 (44.6%) 
592 (13.0%) 
283 (6.2%) 
715 (15.7%) 
348 (7.6%) 
588 (12.9%) 
 
0.08 
0.16 
0.05 
0.08 
0.01 
0.02 
0.01 
 
 
 
 
 
 
Waiting time (months) 37.4 (20.0-66.0) 47.1 (30.0-75.1) 36.3 (19.5-65.7) 0.23 <0.001 
Diabetes 880 (17.8%) 49 (13.0%) 831 (18.2%) 0.12 0.01 
Smoking 635 (12.9%) 42 (11.1%) 593 (13.1%) 0.05 0.28 
IHD 838 (17.0%) 51 (13.5%) 787 (17.3%) 0.08 0.06 
CVD 227 (4.6%) 9 (2.4%) 218 (4.8%) 0.10 0.03 
PVD 322 (6.5%) 14 (3.7%) 308 (6.8%) 0.11 0.02 
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Donor source  
   Live 
   DBD 
   DCD 
 
1355 (27.5%) 
3043 (61.7%) 
537 (10.9%) 
 
89 (23.5%) 
230 (60.9%) 
59 (15.6%) 
 
1266 (27.8%) 
2813 (61.7%) 
478 (10.5%) 
 
0.08 
0.01 
0.13 
0.01 
 
 
 
Male donor 2576 (52.2%) 195 (51.6%) 2381 (52.3%) 0.01 0.80 
Donor age (years) 46.6 ± 15.7 46.6 ± 15.7 46.8 ± 15.7 0.01 0.80 
Donor terminal 
creatinine (umol/L)† 
73 (58-96) 71 (57-94) 73 (58-97) 0.01 0.42 
Transplant era 
   2000-2004 
   2005-2009 
   2010-2014 
 
1033 (20.9%) 
1720 (34.9%) 
2182 (44.2%) 
 
28 (7.4%) 
145 (38.4%) 
205 (54.2%) 
 
1005 (22.1%) 
1575 (34.6%) 
1977 (43.4%) 
 
0.37 
0.06 
0.18 
<0.001 
 
 
 
Transplant state 
   New South Wales 
   Victoria 
   Queensland 
   South Australia 
   Western Australia 
   New Zealand 
 
1273 (25.8%) 
1304 (26.4%) 
817 (16.6%) 
523 (10.6%) 
421 (8.5%) 
597 (12.1%) 
 
117 (31.0%) 
120 (31.8%) 
78 (20.6%) 
4 (1.1%) 
9 (2.4%) 
50 (13.2%) 
 
1156 (25.4%) 
1184 (26.0%) 
739 (16.2%) 
519 (11.4%) 
412 (9.0%) 
547 (12.0%) 
 
0.10 
0.11 
0.09 
0.32 
0.22 
0.03 
<0.001 
 
 
 
 
 
 
Total ischaemia (hours) 10.1 ± 6.1 9.7 ±-5.2 10.1 ± 6.1 0.07 0.23 
HLA mismatches 
   0 
   1 
   2 
   3 
   4 
   5 
   6 
 
245 (5.0%) 
418 (8.5%) 
1046 (21.1%) 
903 (18.3%) 
856 (17.4%) 
971 (19.7%) 
496 (10.1%) 
 
17 (4.5%) 
25 (6.6%) 
97 (25.7%) 
49 (13.0%) 
59 (15.6%) 
80 (21.2%) 
51 (13.5%) 
 
228 (5.0%) 
393 (8.6%) 
949 (20.8%) 
854 (18.7%) 
797 (17.5%) 
891 (19.6%) 
445 (9.8%) 
 
0.02 
0.06 
0.09 
0.13 
0.04 
0.03 
0.10 
0.01 
 
 
 
 
 
 
 
Prior graft 261 (5.3%) 30 (7.9%) 231 (5.1%) 0.10 0.02 
ATSI, Aboriginal and Torres Strait Islander; BMI, body mass index; CVD, cerebrovascular disease; DBD, donation after 
brain death; DCD, donation after circulatory death; ESKD, end stage kidney disease; GN, glomerulonephritis; HD, 
haemodialysis; HLA, human leukocyte antigen; IHD, ischaemic heart disease; MPI, Maori and Pacific Islander; PVD, 
peripheral vascular disease. †Deceased donor kidney recipients only. 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Table 2. Proportion of patients with delayed graft function, acute rejection, graft 
failure, all-cause and cardiovascular mortality, and a composite of graft failure or 
mortality in 378 extended hour haemodialysis (HD) patients compared with 4557 
conventional HD patients. 
 
All 
(n = 4935) 
Extended hour HD 
(n = 378) 
Conventional HD 
(n = 4557) 
P value 
 
Early graft function    <0.001 
 IGF 2956 (59.9%) 187 (49.5%) 2769 (60.8%)  
 SGF 730 (14.8%) 77 (20.4%) 653 (14.3%)  
 DGF-D 1249 (25.3%) 114 (30.1%) 1135 (24.9%)  
Acute rejection episodes    0.82 
 0 3562 (72.2%) 275 (72.8%) 3287 (72.1%)  
  1 973 (19.7%) 71 (18.8%) 902 (19.8%)  
 2 273 (5.5%) 22 (5.8%) 251 (5.5%)  
 ≥3 127 (2.6%) 10 (2.6%) 117 (2.6%)  
Graft failure 618 (12.5%) 36 (9.5%) 582 (12.8%) 0.07 
All-cause mortality 652 (13.2%) 23 (6.1%) 629 (13.8%) <0.001 
Cardiovascular mortality 178 (3.6%) 8 (2.1%) 170 (3.7%) 0.11 
Composite outcome† 1099 (22.3%) 52 (13.8%) 1047 (23.0%) <0.001 
DGF-D, delayed graft function requiring dialysis within 72 hours following transplantation; HD, haemodialysis; IGF, 
immediate graft function defined as a spontaneous fall in serum creatinine of at least 10% within 24 hours; SGF, slow graft 
function defined as a spontaneous fall in serum creatinine of less than 10% within 24 hours; †Composite of graft failure or 
death.
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Table 3. Unadjusted and multivariable adjusted regression analyses of post-kidney 
transplant outcomes in 378 extended hour haemodialysis (HD) patients compared with 
4557 conventional HD patients. 
 Unadjusted analysis Adjusted analysis 
 OR, IRR, Coef or 
HR 
95% CI P value OR, IRR, Coef or 
HR 
95% CI P value 
Delayed graft function 1.47* 1.21-1.79 <0.001 1.33* 1.06-1.67 0.01 
Post-transplant dialysis 1.30* 1.03-1.64 0.02 1.23* 0.94-1.61 0.12 
Acute rejection 1.14¶ 0.93-1.39 0.20 0.95¶ 0.77-1.17 0.61 
12 month eGFR -1.77† -3.89-0.35 0.10 -1.40† -3.32-0.53 0.16 
Graft failure 0.88§ 0.63-1.23 0.45 0.89§ 0.63-1.26 0.51 
All-cause mortality 0.55§ 0.36-0.83 0.004 0.82§ 0.53-1.25 0.35 
Cardiovascular mortality 0.71§ 0.35-1.44 0.34 1.15§ 0.56-2.40 0.70 
Composite outcome‡ 0.71§ 0.54-0.94 0.02 0.83§ 0.63-1.11 0.22 
CI, confidence interval; †Coef, linear regression coefficient; ‡Composite of graft failure or death; eGFR, estimated 
glomerular filtration rate; §HR, hazard ratio; ¶IRR, incidence rate ratio; *OR, odds ratio.
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Table 4. Cause of graft failure and death in 378 extended hour haemodialysis (HD) 
patients compared with 4557 conventional HD patients. 
 Extended hour HD Conventional HD P value 
Cause of graft failure    0.78 
 Rejection 21 (67%) 106 (52%)  
 Vascular 3 (9%) 24 (12%)  
 Technical 2 (6%) 9 (4%)  
 Glomerulonephritis 2 (6%) 19 (9%)  
 Drug therapy 1 (3%) 28 (14%)  
 Other 3 (9%) 19 (9%)  
Cause of death   0.40 
 Cardiac 8 (35%) 170 (27%)  
 Vascular 3 (13%) 52 (8%)  
 Infection 4 (17%) 123 (20%)  
 Social 4 (17%) 66 (10%)  
 Other 4 (17%) 218 (35%)  
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